Mikhail Yu Samsonov (Mikhail Samsonov)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 3

Top Topics

Interstitial Lung Disease

St Elevation Myocardial Infarction

Top Venues

British journal of clinical pharmacology

Molecules (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Svetlana Agachi, Marina I Beloukhova, Diane Mould, Maria Lemak, Sergey Grishin, Mikhail Yu Samsonov
Inflammation-mediated drug interactions of olokizumab and cytochrome P450 activities in patients with rheumatoid arthritis. British journal of clinical pharmacology (2024)
Antonio Abbate, Benjamin W Van Tassell, Vlad Bogin, Roshanak Markley, Dmitry V Pevzner, Paul C Cremer, Imad Meray, Dmitry V Privalov, Angela Taylor, Sergey A Grishin, Alina N Egorova, Ekaterina G Ponomar, Yan Lavrovsky, Mikhail Yu Samsonov, null null
Results of International, Double-Blind, Randomized, Placebo-Controlled, Phase IIa Study of Interleukin-1 Blockade With RPH-104 (Goflikicept) in Patients With ST-Segment-Elevation Myocardial Infarction (STEMI). Circulation 150 (7) (2024)
Nikolay Kuzmich, Elena Andresyuk, Yuri Porozov, Vadim Tarasov, Mikhail Yu Samsonov, Nina Preferanskaya, Valery Veselov, Renad Alyautdin
PCSK9 as a Target for Development of a New Generation of Hypolipidemic Drugs. Molecules (Basel, Switzerland) 27 (2) (2022)